These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 928852)

  • 21. [Therapeutic studies of Clostridium butyricum spores, cyclophosphamide and prednisolone in amelanotic melanoma in Syrian gold hamsters].
    Kretschmer H; Ludewig R; Hambsch K; Wohlrab W; Peker J
    Dermatol Monatsschr; 1973 Dec; 159(12):1089-94. PubMed ID: 4802043
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy for tumours using clostridial oncolysis, antibiotics and cyclophosphamide: model trial on the UVT 15264 tumour.
    Schlechte H; Schwabe K; Mehnert WH; Schulze B; Bräuniger H
    Arch Geschwulstforsch; 1982; 52(1):41-8. PubMed ID: 7082130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further progress with oncolysis due to local high frequency hyperthermia, local x-irradiation and apathogenic clostridia.
    Gericke D; Dietzel F; Rüster I
    J Microw Power; 1979 Jun; 14(2):163-6. PubMed ID: 259088
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tumor hyperthermia using high frequency for increase of oncolysis by clostridium butyricum (M 55)].
    Dietzel F; Gericke D; König W
    Strahlentherapie; 1976 Dec; 152(6):537-41. PubMed ID: 1006715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serological investigations with clostridial spores for tumour diagnosis. III. Experiments for tumour detection in early growth stages of jensen sarcoma in the rat (author's transl)].
    Kretschmer H; Hambsch K; Ludewig R; Grässer A
    Arch Geschwulstforsch; 1974; 44(2):100-2. PubMed ID: 4451433
    [No Abstract]   [Full Text] [Related]  

  • 26. Methodological aspects of a serodiagnostic Clostridium tumour test--experience with spontaneous canine tumours.
    Fabricius EM; Schneeweiss U; Schmidt W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):99-112. PubMed ID: 3673339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying and purifying protective immunogens from cultures of Clostridium chauvoei.
    Hauer PJ; Rosenbusch RF
    Dev Biol Stand; 1996; 86():332. PubMed ID: 8785972
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunocytochemistry of Clostridium novyi antigens. Electron microscopic research].
    Vaĭsman ISh; Postanogova GV; Chemurzieva NV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 May; (5):49-52. PubMed ID: 3524081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ; Clough NE
    Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Behaviour of clostridial antibodies in rats with transplantable tumours under therapy by cyclophosphamide (author's transl)].
    Kretschmer H; Hambsch K; Ludewig R
    Arch Geschwulstforsch; 1974; 44(2):103-5. PubMed ID: 4471604
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on the Clostridia tumor phenomenon with regard to localization of 131I-labeled anti-clostridia-rod-antibodies. 1. Selection of a suitable tumor model].
    Mehnert WH
    Arch Geschwulstforsch; 1982; 52(7):535-40. PubMed ID: 7165489
    [No Abstract]   [Full Text] [Related]  

  • 32. The tumour-Clostridium phenomenon: 50 years of developmental research (Review).
    Schmidt W; Fabricius EM; Schneeweiss U
    Int J Oncol; 2006 Dec; 29(6):1479-92. PubMed ID: 17088987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differentiation of Cl. sordelli and Cl. bifermentans by their thermostable antigens].
    Egorova GK; Bychenko BD; Kurdina DS; Bocharova NG
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Apr; (4):37-9. PubMed ID: 7405451
    [No Abstract]   [Full Text] [Related]  

  • 34. A serological potency assay for Clostridium chauvoei.
    Hauer PJ; Whitaker MS; Henry LA
    Dev Biol Stand; 1996; 86():331. PubMed ID: 8785971
    [No Abstract]   [Full Text] [Related]  

  • 35. Demonstration of shared antigens in the genus Clostridium by an enzyme-linked immunosorbent assay.
    Poxton IR; Byrne MD
    J Med Microbiol; 1984 Apr; 17(2):171-6. PubMed ID: 6323714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid Endospore Viability Assay of Clostridium sporogenes spores.
    Yang WW; Ponce A
    Int J Food Microbiol; 2009 Aug; 133(3):213-6. PubMed ID: 19540610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium spores as anti-tumour agents.
    Van Mellaert L; Barbé S; Anné J
    Trends Microbiol; 2006 Apr; 14(4):190-6. PubMed ID: 16500103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temperature and cell survival variability across 9L subcutaneous tumors heated with microwaves.
    Wallen CA; Michaelson SM; Wheeler KT
    Radiat Res; 1981 Feb; 85(2):281-91. PubMed ID: 7465782
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of preparations of microbial origin for stimulating antitumor resistance].
    Zatula DG; Zaval'niuk AK
    Eksp Onkol; 1986; 8(6):3-9. PubMed ID: 3542497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Field studies in sheep with multicomponent clostridial vaccines.
    Kerry JB; Craig GR
    Vet Rec; 1979 Dec; 105(24):551-4. PubMed ID: 532068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.